| Year |
Citation |
Score |
| 2023 |
Bi X, Xie S, Wu S, Cao W, Lin Y, Yang L, Jiang T, Deng W, Wang S, Liu R, Gao Y, Shen G, Chang M, Hao H, Xu M, et al. Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy. Frontiers in Immunology. 14: 1116689. PMID 36793722 DOI: 10.3389/fimmu.2023.1116689 |
0.335 |
|
| 2023 |
Zhang L, Bi X, Chen X, Zhang L, Xiong Q, Cao W, Lin Y, Yang L, Jiang T, Deng W, Wang S, Wu S, Liu R, Gao Y, Shen G, et al. A nomogram based on HBeAg, AST, and age to predict non-minimal liver inflammation in CHB patients with ALT <80 U/L. Frontiers in Immunology. 13: 1119124. PMID 36741383 DOI: 10.3389/fimmu.2022.1119124 |
0.343 |
|
| 2023 |
Zeng Z, Liu R, Cao W, Yang L, Lin Y, Bi X, Jiang T, Deng W, Wang S, Lu H, Sun F, Shen G, Chang M, Lu Y, Wu S, et al. Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative. Frontiers in Immunology. 13: 1113070. PMID 36685494 DOI: 10.3389/fimmu.2022.1113070 |
0.339 |
|
| 2022 |
Sun F, Li Z, Hu L, Deng W, Jiang T, Wang S, Bi X, Lu H, Yang L, Lin Y, Zeng Z, Shen G, Liu R, Chang M, Wu S, et al. Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection. Frontiers in Immunology. 13: 1082091. PMID 36505492 DOI: 10.3389/fimmu.2022.1082091 |
0.349 |
|
| 2022 |
Zeng Z, Hao H, Bi X, Lin Y, Yang L, Wang S, Shen G, Chang M, Jiang T, Deng W, Lu H, Sun F, Lu Y, Gao Y, Liu R, et al. Study on liver histopathology of chronic HBV infected patients with different normal ALT values. Frontiers in Immunology. 13: 1069752. PMID 36483546 DOI: 10.3389/fimmu.2022.1069752 |
0.329 |
|
| 2022 |
Cao W, Lu H, Zhang L, Wang S, Deng W, Jiang T, Lin Y, Yang L, Bi X, Lu Y, Zhang L, Shen G, Liu R, Chang M, Wu S, et al. Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy. Frontiers in Immunology. 13: 1067362. PMID 36479104 DOI: 10.3389/fimmu.2022.1067362 |
0.33 |
|
| 2022 |
Wang F, Song M, Hu Y, Yang L, Bi X, Lin Y, Jiang T, Deng W, Wang S, Sun F, Zeng Z, Lu Y, Shen G, Liu R, Chang M, et al. The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection. Frontiers in Immunology. 13: 1062123. PMID 36439153 DOI: 10.3389/fimmu.2022.1062123 |
0.307 |
|
| 2022 |
Xie S, Yang L, Bi X, Deng W, Jiang T, Lin Y, Wang S, Zhang L, Liu R, Chang M, Wu S, Gao Y, Hao H, Shen G, Xu M, et al. Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis B. Frontiers in Immunology. 13: 1036612. PMID 36353632 DOI: 10.3389/fimmu.2022.1036612 |
0.317 |
|
| 2022 |
Li M, Gao Y, Yang L, Lin Y, Deng W, Jiang T, Bi X, Lu Y, Zhang L, Shen G, Liu R, Wu S, Chang M, Xu M, Hu L, et al. Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Frontiers in Immunology. 13: 1024333. PMID 36203581 DOI: 10.3389/fimmu.2022.1024333 |
0.365 |
|
| 2022 |
Cao W, Xie S, Zhang L, Bi X, Lin Y, Yang L, Lu Y, Liu R, Chang M, Wu S, Shen G, Dong J, Xie Y, Li M. Expression of Functional Molecule on Plasmacytoid Dendritic Cells Is Associated With HBsAg Loss in HBeAg-Positive Patients During PEG-IFN α-2a Treatment. Frontiers in Immunology. 13: 891424. PMID 35663955 DOI: 10.3389/fimmu.2022.891424 |
0.301 |
|
| 2022 |
Wu S, Yi W, Gao Y, Deng W, Bi X, Lin Y, Yang L, Lu Y, Liu R, Chang M, Shen G, Hu L, Zhang L, Li M, Xie Y. Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection. Frontiers in Immunology. 13: 893512. PMID 35634301 DOI: 10.3389/fimmu.2022.893512 |
0.372 |
|
| 2022 |
Li M, Zhang L, Xie S, Sun F, Zeng Z, Deng W, Jiang T, Bi X, Lin Y, Yang L, Lu Y, Shen G, Liu R, Wu S, Chang M, et al. Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Frontiers in Immunology. 13: 892031. PMID 35603222 DOI: 10.3389/fimmu.2022.892031 |
0.341 |
|
| 2021 |
Cao W, Li M, Zhang L, Lu Y, Wu S, Shen G, Chang M, Liu R, Gao Y, Hao H, Hu L, Yi W, Pan CQ, Xie Y. The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy. Biomed Research International. 2021: 2178143. PMID 33575322 DOI: 10.1155/2021/2178143 |
0.385 |
|
| 2021 |
Pan CQ, Li MH, Yi W, Zhang L, Lu Y, Hao HX, Wan G, Cao WH, Wang XY, Ran CP, Shen G, Wu SL, Chang M, Gao YJ, Xie Y. Outcome of Chinese Patients with Hepatitis B at 96 Weeks after Functional Cure With IFN versus Combination Regimens. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33486874 DOI: 10.1111/liv.14801 |
0.382 |
|
| 2020 |
Liu R, Chen Y, Guo J, Li M, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Zhang H, Xie Y. The reduction in CD8PD-1 T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patients. Bmc Infectious Diseases. 20: 590. PMID 32778058 DOI: 10.1186/s12879-020-05320-z |
0.314 |
|
| 2019 |
Xie Y, Yi W, Zhang L, Lu Y, Hao HX, Gao YJ, Ran CP, Lu HH, Chen QQ, Shen G, Wu SL, Chang M, Ping-Hu L, Liu RY, Sun L, et al. Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levels. Journal of Viral Hepatitis. 26: 42-49. PMID 31380591 DOI: 10.1111/jvh.13163 |
0.314 |
|
| 2019 |
Li MH, Yi W, Zhang L, Lu Y, Lu HH, Shen G, Wu SL, Hao HX, Gao YJ, Chang M, Liu RY, Hu LP, Cao WH, Chen QQ, Li JN, et al. Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy. Journal of Viral Hepatitis. 26: 32-41. PMID 31380582 DOI: 10.1111/jvh.13151 |
0.354 |
|
| 2019 |
Liu R, Guo J, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Li M, Xie Y. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy. Clinical and Experimental Medicine. PMID 31111345 DOI: 10.1007/s10238-019-00560-z |
0.307 |
|
| 2018 |
Li MH, Lu Y, Zhang L, Wang XY, Ran CP, Hao HX, Zhang D, Qu XJ, Shen G, Wu SL, Cao WH, Qi TL, Liu RY, Hu LP, Chang M, et al. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B. Chinese Medical Journal. 131: 1813-1818. PMID 30058578 DOI: 10.4103/0366-6999.237394 |
0.326 |
|
| 2017 |
Zhang L, Li MH, Cao WH, Qi TL, Lu Y, Wu SL, Hao HX, Shen G, Liu RY, Hu LP, Chang M, Hua WH, Song SJ, Wan G, Xie Y. Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection. Chinese Medical Journal. 130: 2697-2702. PMID 29133758 DOI: 10.4103/0366-6999.218000 |
0.376 |
|
| 2017 |
Li MH, Zhang D, Zhang L, Qu XJ, Lu Y, Shen G, Wu SL, Chang M, Liu RY, Hu LP, Hao HX, Hua WH, Song SJ, Wan G, Liu SA, et al. Ratios of T-helper 2 Cells to T-helper 1 Cells and Cytokine Levels in Patients with Hepatitis B. Chinese Medical Journal. 130: 1810-1815. PMID 28748854 DOI: 10.4103/0366-6999.211541 |
0.302 |
|
| 2017 |
Li MH, Zhang L, Qu XJ, Lu Y, Shen G, Wu SL, Chang M, Liu RY, Hu LP, Li ZZ, Hua WH, Song SJ, Xie Y. Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment. Chinese Medical Journal. 130: 559-565. PMID 28229987 DOI: 10.4103/0366-6999.200554 |
0.37 |
|
| 2015 |
Li MH, Hu LP, Zhang L, Lu Y, Shen G, Wu SL, Chang M, Mu CQ, Wu YZ, Yang M, Song SJ, Zhang SF, Hua WH, Xie Y, Cheng J, et al. [Efficacy of pegylated-interferon alpha-2a treatment in patients with HBeAg-positive chronic hepatitis B and partial viral response to nucleoside analogue therapy]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 23: 826-31. PMID 26743242 DOI: 10.3760/cma.j.issn.1007-3418.2015.11.006 |
0.367 |
|
| 2013 |
Zhao JM, Zhang L, Du QW, Mu CQ, Ren YL, Hu LP, Shen G, Zhuang LW, Lu Y, Qiu GH, Sun QF, Wu YZ, Yang M, Li MH, Xie Y, et al. [Analyse related factors of impact and prognosis of 73 cases of severe hepatitis]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 27: 366-9. PMID 24645325 |
0.345 |
|
| 2012 |
Li MH, Zhang YL, Zhang L, Shen G, Qiu GH, Lu Y, Zhuang LW, Gao YJ, Yang M, Wu Y, Xie Y, Cheng J, Xu D. [Study on effect of intensive treatment for refractory chronic hepatitis C patients]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 26: 374-8. PMID 23550318 |
0.371 |
|
| 2011 |
Lu Y, Zhang YL, Shen G, Zhang L, Wang L, Qiu GH, Wu YZ, Yang M, Li MH. [Clinical study on viral hepatitis combined with aplastic anemia]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 25: 283-5. PMID 22097608 |
0.341 |
|
| Show low-probability matches. |